Supplied for research purposes only. These peptides are laboratory reagents intended for qualified researchers and educational institutions. Not for human use, animal use, or clinical application.
DSIP (Delta Sleep-Inducing Peptide) is a synthetic, nonapeptide originally isolated from human plasma, engineered to investigate endogenous sleep modulation, stress-axis regulation, and neuroendocrine homeostasis. It has become a high-interest compound in preclinical chronobiology, HPA axis, and opioid-receptor-adjacent signalling research due to its multimodal effects on slow-wave sleep, corticosterone rhythms, and antioxidant enzyme expression β without direct GABAergic or sedative mechanisms. This DSIP research peptide is supplied as a lyophilised solid to ensure stability, purity, and reproducibility in laboratory and investigative settings.
Supplied in lyophilised (freeze-dried) form to preserve stability.
What is the DSIP Research Peptide?
DSIP (CββHββNββOββ, MW: 892.00 g/mol) is a 9-amino-acid peptide with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, first characterised from porcine cerebral venous blood by Schally et al. (PNAS 1977). Unlike unverified commercial variants, NovaVitalityβs DSIP is synthesised with native L-amino acids and validated by LC-MS and in vitro corticosterone modulation assays [Schally AV et al., Proc Natl Acad Sci USA 1977; 74(12):5498β5502; DOI: 10.1073/pnas.74.12.5498]. Supplied exclusively for in vitro, ex vivo, and preclinical research β not for human or veterinary use.
π¬ Note: Despite its name, DSIPβs effects on human sleep remain unproven. This RUO material is intended solely for mechanistic neuroendocrine and chronobiology research β not sleep aid or nootropic applications.
Scientific Identifiers
Field
Value
Product Name
DSIP Research Peptide
Catalogue Numbers
NV-DSIP-10
CAS Number
62548-94-1
Molecular Formula
CββHββNββOββ
Molecular Weight
892.00 g/mol (monoisotopic)
Amino Acid Sequence
H-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu-OH
Form
Lyophilised Solid (white to off-white powder)
Purity
β₯98% (HPLC-UV, isocratic elution)
Storage
Store at β20Β°C, protected from light and moisture
Unit Sizes
10 mg
Usage and Reconstitution
The DSIP research peptide is supplied freeze-dried for stability. For experimental protocols, reconstitute using: β Sterile bacteriostatic water (0.9% benzyl alcohol in 0.9% NaCl), or β Sterile saline (0.9% NaCl) β preferred for in vivo CNS studies.
β οΈ Critical Handling Notes: β Highly soluble β typically dissolves fully with gentle swirling (no warming or sonication needed). β Avoid acetic acid β may reduce stability of Aspβ΅/GluβΉ residues over time. β Filter through a 0.22 Β΅m PVDF syringe filter for ICV or intranasal studies.
Post-Reconstitution Storage: β Short-term: 2β8Β°C for β€7 days β Long-term: Aliquot and store at β80Β°C (β€5 freezeβthaw cycles tolerated β DSIP is highly stable in solution)
π Recommended reconstitution accessories will be auto-added to cart β Adjust before checkout.
DSIP Research Peptide: Key Investigational Pathways
DSIP is actively studied for its neuroendocrine and chronobiological modulation. Key research applications include:
HPA Axis & Stress Response
Investigated in:
β Rat hypothalamic explants for CRH release modulation
β Plasma corticosterone rhythms (diurnal vs. stress-induced)
β Glucocorticoid receptor (GR) nuclear translocation (immunofluorescence)
π Research-first ethos: No βsleep aidβ or βnootropicβ claims β full technical & protocol support
π‘οΈ RUO integrity: Meets expectations under MHRA GMP Guide, FDA 21 CFR 1271, EU GMP Annex 1
π¬ Expert support: Get guidance on ICV dosing, EEG study design, or corticosterone assay optimisation
Legal and Safety Information
NovaVitality supplies DSIP strictly for laboratory research, assay development, and educational purposes (RUO).
β This product is not approved by the MHRA, FDA, EMA, or any regulatory authority for: β Human use β Veterinary use β Diagnostic, therapeutic, sleep aid, or supplement use
β οΈ Critical Responsibilities for Researchers: β Use only under approved institutional biosafety protocols β Comply with local ethics oversight (e.g., AWERB for in vivo work) β Maintain full chain-of-custody documentation β Do not compound, dispense, or administer to living subjects
π NovaVitality disclaims all liability for unauthorised or off-label use. By purchasing, you affirm compliance with all applicable laws and institutional policies.
Ready to Advance Chronobiology & Neuroendocrine Research?